Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor. [electronic resource]
- British journal of cancer Jun 2014
- 2965-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't